Intra Globus Biosystems Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 3.61 M
- Company Age 7 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 210.14%
- Profit Growth -304.59%
- Ebitda -854.11%
- Net Worth -372.33%
- Total Assets 81.75%
About Intra Globus Biosystems
Intra Globus Biosystems Private Limited (IGBPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 January 2018 (Seven years 11 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.61 M, as per Ministry of Corporate Affairs (MCA) records.
Mamatha Rangaprasad, Bimal Somasekharan, and Sampath Prabhu serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999KA2018PTC109850
-
Company No.
109850
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jan 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Intra Globus Biosystems?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamatha Rangaprasad
|
Director | 29-Jan-2018 | Current |
|
Bimal Somasekharan
|
Director | 29-Jan-2018 | Current |
|
Sampath Prabhu
|
Director | 29-Jan-2018 | Current |
Financial Performance of Intra Globus Biosystems.
Intra Globus Biosystems Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 210.14% increase. The company also saw a substantial fall in profitability, with a 304.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 372.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intra Globus Biosystems?
In 2020, Intra Globus Biosystems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Prismbiz Sol Private LimitedMamatha Rangaprasad is a mutual person
-
Pansoft Technologies Private LimitedMamatha Rangaprasad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Intra Globus Biosystems?
Unlock and access historical data on people associated with Intra Globus Biosystems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intra Globus Biosystems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intra Globus Biosystems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.